Skip to main
AZTA
AZTA logo

Azenta (AZTA) Stock Forecast & Price Target

Azenta (AZTA) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Azenta Inc. reported an impressive adjusted gross margin of 47.5%, reflecting a year-over-year increase of 130 basis points, attributed to a favorable product mix, operational efficiencies, and revenue growth. The company's adjusted EBITDA margin also demonstrated significant improvement, rising 400 basis points year-over-year to 10.0%, surpassing analyst expectations. With strong revenue growth potential projected from its Multiomics and Sample Management Solutions segments, Azenta is poised for enhanced profitability and faster margin improvements.

Bears say

The financial outlook for Azenta Inc is viewed negatively due to anticipated lower revenue growth, driven primarily by heightened competition in the Multiomics sector and slower traction within the Sample Management Solutions segment. Additionally, declines in automated and cryogenic stores highlight a decreasing demand, particularly in the cell and gene therapy market, which may further impact overall profitability. These factors contribute to concerns regarding margin contraction and the potential for slowing or negative earnings per share growth.

Azenta (AZTA) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Azenta (AZTA) Forecast

Analysts have given Azenta (AZTA) a Buy based on their latest research and market trends.

According to 5 analysts, Azenta (AZTA) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Azenta (AZTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.